PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extracts (particularly aqueous and ethyl acetate) act as potent inhibitors of α-glucosidase and lipase in vitro [PMID:32984977, 32627774]
Extracts significantly suppressed anaphylactic reaction-induced body temperature decline and inhibited antigen-antibody-induced degranulation in a murine model [PMID:38966058]
Extracts demonstrate mitochondria-enhancing and ameliorative properties under oxidative stress in human neuroblastoma cells [PMID:32831989]
Aqueous extract of fermented honeybush tea inhibited osteoclast formation and TRAP activity in murine macrophages in vitro [PMID:26516894]
Selected constituents showed pro-apoptotic activity on TNF-α-stimulated synovial cells from patients [PMID:23916580]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32984977 (2020) — Sequential extracts of red honeybush (Cyclopia genistoides) tea: Chemical characterization, antioxidant potentials, and anti-hyperglycemic activities. · Journal of food biochemistry
- 2.PMID: 32831989 (2020) — Honeybush Extracts (Cyclopia spp.) Rescue Mitochondrial Functions and Bioenergetics against Oxidative Injury. · Oxidative medicine and cellular longevity
- 3.PMID: 15315375 (2004) — Phenolic metabolites from honeybush tea (Cyclopia subternata). · Journal of agricultural and food chemistry
- 4.PMID: 31554050 (2019) — Potential of benzophenones and flavanones to modulate the bitter intensity of Cyclopia genistoides herbal tea. · Food research international (Ottawa, Ont.)
- 5.PMID: 34312869